SCHEMBL29574690

SCHEMBL29574690

Cc1cc(N)nnc1C1=C[C@H](C)N(C(=O)OC(C)(C)C)CC1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 2/20 0.36
SMARCA2 P51531 2/20 0.34
SMARCA4 P51532 2/20 0.34
PBRM1 Q86U86 2/20 0.34
NPSR1 Q6W5P4 2/20 0.34
LMNA P02545 1/20 0.34
GRM5 P41594 4/20 0.33
GRM1 Q13255 4/20 0.33
CYP1A2 P05177 1/20 0.33
POLB P06746 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C19 P33261 1/20 0.33
MAP4K4 O95819 1/20 0.33
UCHL1 P09936 1/20 0.33
ACACB O00763 1/20 0.33
TNK2 Q07912 1/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
MAPT P10636 1/20 0.31
SCN4A P35499 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22550617 1.00 NR1H2 (0.36) NR1H2SMARCA2SMARCA4PBRM1NPSR1
SCHEMBL22529749 0.84 TRPC6 (0.32)
SCHEMBL30426810 0.80 SMARCA2 (0.39) NR1H2SMARCA2SMARCA4PBRM1GRM5
SCHEMBL31105081 0.80 SMARCA2 (0.39) NR1H2SMARCA2SMARCA4PBRM1GRM5
SCHEMBL31105132 0.80 SMARCA2 (0.39) NR1H2SMARCA2SMARCA4PBRM1GRM5
SCHEMBL31104864 0.80 SMARCA2 (0.39) NR1H2SMARCA2SMARCA4PBRM1GRM5
SCHEMBL30426870 0.80 SMARCA2 (0.39) NR1H2SMARCA2SMARCA4PBRM1GRM5
SCHEMBL30427091 0.80 SMARCA2 (0.39) NR1H2SMARCA2SMARCA4PBRM1GRM5
SCHEMBL22550615 0.79 NPSR1 (0.34) NR1H2SMARCA2SMARCA4PBRM1NPSR1
SCHEMBL21045788 0.78 GRM1 (0.52) GRM5GRM1TNK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12156874-B2 Inhibitors of TRPC6 BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2024-12-03 US disclosed
US-20220152023-A1 INHIBITORS OF TRPC6 BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2022-05-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220152023-A1 INHIBITORS OF TRPC6 TRPC6, TRPC1, TRPC3 NR1H2 229/4885SMARCA2 3868/4885SMARCA4 3531/4885
US-12156874-B2 Inhibitors of TRPC6 TRPC6, TRPC1, TRPC3 NR1H2 229/4885SMARCA2 3868/4885SMARCA4 3531/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.